News

A blood test can help identify rare mutations in advanced breast cancer, which may enable patients to access effective treatments more quickly in the future, Cancer Research UK scientists have found. As part of the plasmaMATCH clinical trial, funded by Stand Up To Cancer, a joint…

2019 was a year jam packed  with  brilliant progress and  new  challenges for cancer research. Here are some of the top stories of the year:  Re-writing the breast cancer rulebook, A cancer breath test enters trials, three new teams take on some of the biggest challenges in cancer research, tracking cancer evolution with…

Cancer Research UK and Vaccitech Oncology Limited (VOLT), announced Wednesday that a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer. The vaccine treatment developed by VOLT, a strategic collaboration between Vaccitech Ltd and the Ludwig Institute for Cancer Research, is…

New headlines on cancer research: -A prostate cancer MRI trial is in progress -Treatment that delivers drugs straight to tumor given for the first time -WHO approves cheap copy of common breast cancer drug -Facebook bans ads promoting fake cancer "cures" -Post-menopausal women who are overweight…

Specialists warn that single number average survival estimates for advanced stage breast cancer are unhelpful and usually inaccurate. Instead, they advise doctors to provide several case-specific survival estimates to help people plan with realism and hope. Breast cancer is the form of cancer that affects women…

The U.S. Food and Drug Administration recently approved a treatment that combines an immunotherapy drug and chemotherapy for triple negative breast cancer, but not all cases of this aggressive form of breast cancer responded in clinical studies. UNC Lineberger researchers discovered biological…

The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells according to a study published in Nature Communications. Researchers from the Babraham Institute, AstraZeneca and the Cancer Research UK Cambridge Centre have…